I would to add that we've consulted with our board, with our provincial pharmacists associations, and with individual members. When the bill was introduced back in December, we issued a public statement.
As many of the members around this table know, we've worked on various issues related to drug safety. For example, we've worked with Mr. Wilks on prescription drug take-back days. A number of issues involve the broader issue of drug safety, and we've worked with and consulted with our members about them.
As I said in my opening comments, this is priority number one for pharmacists.